Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stepping up at RCOT.

The British journal of occupational therapy·2025
Same author

Characterisation and optimisation of diclofenac sodium orodispersible thin film formulation.

International journal of pharmaceutics·2019
Same author

Nurses' views on impact of referendum revealed.

Nursing times·2016
Same author

Bursary consultation launched.

Nursing times·2016
Same author

Nursing leaders welcome CNO for England's new framework.

Nursing times·2016
Same author

Meeting nurses' needs cited as key to reducing staff turnover.

Nursing times·2016
Same journal

'The little things count': delivering dignified care.

Nursing times·2018
Same journal

The heart of the hospital.

Nursing times·2018
Same journal

The nurse's role in caring for people with dementia.

Nursing times·2018
Same journal

Hepatitis C and the ongoing challenge of genotype 3.

Nursing times·2018
Same journal

Implementing change in older people's acute care.

Nursing times·2018
Same journal

A total health economy approach to revalidation.

Nursing times·2018
See all related articles

Related Experiment Video

Updated: May 26, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

Students refused flu vaccination

Steve Ford

    Nursing Times
    |December 15, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
    08:11

    Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

    Published on: September 6, 2016

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    Related Experiment Videos

    Last Updated: May 26, 2026

    Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
    09:31

    Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

    Published on: April 15, 2017

    Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
    08:11

    Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

    Published on: September 6, 2016

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017